About Business
Amgen Inc. was formerly known as Applied Molecular Genetics and is a publicly traded American company. It deals with biopharmaceutical practices. Established on April 8, 1980, and headquartered in Thousand Oaks, California, United States. When the company started, they emphasized recombinant DNA technology. Finally, in 1983, Amgen went public, and soon after that, their team researched the erythropoietin gene, which is necessary for the production of red blood cells. In 1991, the company was approved for Neupogen to control and eliminate the infections in cancer survivors with damaged immune systems. Soon after that, in 1993, the company launched a manufacturing unit, and soon received the U.S. Department of Commerce?s National Medal of Technology and Innovation in 1994.